TheraPanacea

[ Editor's Note: This article originally appeared in In Vivo , Medtech Insight 's sister publication, on 21 September. ] Artificial intelligence technologies can be used to help reduce the tim

Artificial intelligence technologies can be used to help reduce the time it takes to plan external beam radiotherapy (EBRT) for patients with cancer, says draft guidance from the National Institute fo

The reasons driving alliances and deals between pharma and digital health have been well documented; the need for innovation without internal capability, the need to remain commercially competitive th

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Immatics Gets $150m Up Front For Rights